AdvisorShares Investments LLC Boosts Stock Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)
AdvisorShares Investments LLC Boosts Stock Position in Bright Minds Biosciences Inc. (NASDAQ:DRUG)
AdvisorShares Investments LLC lifted its position in Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) by 115.5% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 206,716 shares of the company's stock after buying an additional 110,774 shares during the quarter. AdvisorShares Investments LLC's holdings in Bright Minds Biosciences were worth $314,000 at the end of the most recent quarter.
據Holdings Channel.com報道，今年第一季度，AdvisorShares Investments LLC將其在光明心靈生物科學公司(Bright Minds Biosciences Inc.)的持倉提高了115.5%。該機構投資者在本季度額外購買了110,774股後，持有該公司206,716股股票。截至最近一個季度末，AdvisorShares Investments LLC在Bright Minds Biosciences持有的股份價值31.4萬美元。
Separately, Checchi Capital Advisers LLC acquired a new position in Bright Minds Biosciences during the 4th quarter worth $45,000. Institutional investors own 7.70% of the company's stock.
另外，Checchi Capital Advisers LLC在第四季度收購了Bright Minds Biosciences的一個新頭寸，價值4.5萬美元。機構投資者持有該公司7.70%的股份。
Bright Minds Biosciences Price Performance
Bright Minds生物科學的價格表現
DRUG opened at $0.91 on Friday. Bright Minds Biosciences Inc. has a 12 month low of $0.75 and a 12 month high of $8.95. The business has a fifty day moving average price of $0.93 and a 200 day moving average price of $1.40.
週五，毒品的開盤價為0.91美元。Bright Minds Biosciences Inc.的股價為0.75美元的12個月低點，以及8.95美元的12個月高位。該業務的50日移動平均價為0.93美元，200日移動平均價為1.40美元。
About Bright Minds Biosciences
關於Bright Minds生物科學
(Get Rating)
(獲取評級)
Bright Minds Biosciences Inc, a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry.
Bright Minds Biosciences Inc是一家臨牀前生物科學公司，開發5-羥色胺(5-HT)藥物，以改善嚴重和改變生活的疾病患者的生活。該公司的選擇性5-羥色胺受體激動劑組合包括5-HT2C、5-HT2A和5-HT2C/A，用於治療癲癇、疼痛和神經精神病學。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Bright Minds Biosciences (DRUG)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- Why Apple Could Be At All-Time Highs By Year End
- 免費獲取StockNews.com關於Bright Minds生物科學(藥物)的研究報告
- MarketBeat：回顧中的一週8/1-8/5
- 如何利用高貝塔係數股票最大化你的投資利潤
- 克羅諾斯集團(Cronos Group Inc.)營收上升，是時候收購了嗎？
- Beyond Meat不是沒有希望，而且它很便宜
- 蘋果為何可能在年底創下歷史新高
Want to see what other hedge funds are holding DRUG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating).
想看看還有哪些對衝基金持有毒品嗎？訪問HoldingsChannel.com獲取光明心靈生物科學公司(Bright Minds Biosciences Inc.)最新的13F備案文件和內幕交易(納斯達克：毒品獲取評級)。
Receive News & Ratings for Bright Minds Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Minds Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Bright Minds生物科學日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Bright Minds Biosciences和相關公司的最新新聞和分析師評級的每日簡要摘要。